Hepion Pharms Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,901 | 8,792 | 735 | 1,818 | 2,510 |
| TOTAL | $9,362 | $8,851 | $893 | $1,982 | $2,628 |
| Non-Current Assets | |||||
| PPE Net | 87 | 62 | 56 | 15 | 16 |
| Other Non-Current Assets | 51 | 51 | 56 | 4 | 0 |
| TOTAL | $138 | $113 | $111 | $19 | $16 |
| Total Assets | $9,500 | $8,965 | $1,005 | $2,001 | $2,644 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,313 | 114 | 213 | 244 | 188 |
| Accrued Expenses | 303 | 247 | 244 | 208 | 67 |
| Other current liabilities | N/A | N/A | 7 | 7 | 6 |
| TOTAL | $1,616 | $361 | $465 | $459 | $260 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 4,475 | 9,726 |
| TOTAL | $N/A | $N/A | $N/A | $4,475 | $9,726 |
| Total Liabilities | $1,616 | $361 | $465 | $4,934 | $9,986 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,273 | 22,273 | 22,237 | N/A | 18,479 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -22,239 | -14,841 | -6,892 | -5,421 | -9,803 |
| Other shareholders' equity | 13,700 | 10,700 | 0 | 0 | 0 |
| TOTAL | $7,884 | $8,604 | $540 | $-2,933 | $-7,342 |
| Total Liabilities And Equity | $9,500 | $8,965 | $1,005 | $2,001 | $2,644 |